Rita Martino received her Master’s Degree in Pharmaceutical Chemistry and Technology at the University of Turin in October 2022. She did an experimental thesis in Advanced Pharmaceutical Nanotechnology Laboratory (DSTF, UniTo), working on the development of HPLC protocol to quantify stearoyl-L-carnitine in PLGA nanoparticles for the treatment of Myotonic Distrophy type 1. After graduating, she worked for Sanofi in the department of Quality Assurance Product of sterile production site. In October 2023, she started working at LABION on SEMISOFT project (ERC funded grant) to find biomarkers in human saliva for early diagnosis of Parkinson ‘s disease by using SEMISOFT software and Raman Spectroscopy.

Email: rimartino@dongnocchi.it